Download PDF
doi: 10.53388/ghr2021-03-030
Published online: March 12, 2021
Citation: Chi ZC. Research progress in the imaging diagnosis of non-alcoholic fatty pancreas disease. Gastroenterol & Hepatol Res. 2021;3(1):4. doi: 10.53388/ghr2021-03-030.
Currently, imaging modalities such as ultrasonography, magnetic resonance imaging (MRI), and computed tomography (CT) are considered the method of choice for diagnosing non-alcoholic fatty pancreas disease. In addition, imaging-based clinical examination methods such as B-scan ultrasonography, transient elastography, and MRI-proton density fat fraction are the most widely used and have a high diagnostic value. Endoscopic ultrasonography is more accurate than CT and MRI in diagnosing pancreatic steatosis. MRI is a sensitive, non-invasive, and safe inspection method and also the best imaging technique to assess pancreatic steatosis. However, no clear consensus has been reached on diagnostic methodology for pancreatic fat.
Copyright © 2025 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.